Canada markets closed

Lisata Therapeutics Inc (8NE.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
2.60000.0000 (0.00%)
At close: 08:30PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
12,796
12,734
43,460
17,576
9,253
Selling General and Administrative
12,669
12,974
14,141
11,474
9,892
Total Operating Expenses
25,465
25,708
57,601
29,050
19,145
Operating Income or Loss
-25,465
-25,708
-57,601
-29,050
-19,145
Interest Expense
0
-
-
-
-
Total Other Income/Expenses Net
2,283
2,538
897
76
132
Income Before Tax
-23,182
-23,170
-56,704
-28,974
-19,013
Income Tax Expense
-3,128
-2,330
-2,479
-1,508
-10,872
Income from Continuing Operations
-20,054
-20,840
-54,225
-27,466
-8,141
Net Income
-20,054
-20,840
-54,225
-27,466
-8,150
Net Income available to common shareholders
-20,054
-20,840
-54,225
-27,466
-8,150
Basic EPS
-1.11
-
-10.47
-7.45
-7.95
Diluted EPS
-1.11
-
-10.47
-7.45
-7.95
Basic Average Shares
8,011
-
5,180
3,688
1,029
Diluted Average Shares
8,011
-
5,180
3,688
1,029